Drug Discovery research heavily relies on cell-based assay systems to investigate cellular functions and processes, and to help understand the effect of modulating specific molecular targets. Challenges associated with the use of primary cultures, such as availability, scalability, and cost, make recombinant cellular systems indispensable for drug discovery. High quality recombinant cell lines provide robust, reliable data and support large-scale high throughput screening, as well as enabling downstream medicinal chemistry-driven cascades due to their excellent reproducibility. Sygnature Discovery excels in providing fully validated, stable cell lines and assay systems specifically tailored to meet the complex requirements of drug discovery, supporting target validation through to hit identification and lead optimization.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":15781,"template":"","category":[681,779,781,707,773,775,746,776,774,780,778,687,782,777],"resource_tag":[],"class_list":["post-12857","e-book","type-e-book","status-publish","has-post-thumbnail","hentry","category-bioscience","category-calcium-channels","category-chloride-channels","category-electrophysiology","category-gabaa-receptors","category-glycine-receptors","category-ion-channels","category-nicotinic-receptors","category-nmda-receptors","category-potassium-channels","category-sodium-channels","category-target-classes","category-tmem175","category-trp-channels"],"acf":[],"yoast_head":"\n